CFOR · CapForce Inc.

Represents an award of restricted stock units, 100% vesting on the earlier of (i) 12/3/2026 and (ii) a change in control of the Issuer.

Represents an award of restricted stock units, 100% vesting on the earlier of (i) 12/3/2026 and (ii) a change in control of the Issuer.

Represents an award of restricted stock units, 100% vesting on the earlier of (i) 12/3/2026 and (ii) a change in control of the Issuer.

Represents an award of restricted stock units, 100% vesting on the earlier of (i) 12/3/2026 and (ii) a change in control of the Issuer.

Represents an award of restricted stock units, 100% vesting on the earlier of (i) 12/3/2026 and (ii) a change in control of the Issuer.

Represents an award of restricted stock units, 100% vesting on the earlier of (i) 12/3/2026 and (ii) a change in control of the Issuer.

Represents an award of restricted stock units vesting on the earlier of the (i) first anniversary of the CTO's appointment in the Company and (ii) a change in control; provided that the award is expressly conditioned upon the receipt of stockholder approval of a new equity incentive plan.

Represents an award of restricted stock units vesting on the earlier of the (i) first anniversary of the Corporate Secretary's appointment in the Company and (ii) a change in control; provided that the award is expressly conditioned upon the receipt of stockholder approval of a new equity incentive plan.

Represents an award of restricted stock units vesting on the earlier of the (i) first anniversary of the COO's appointment in the Company and (ii) a change in control; provided that the award is expressly conditioned upon the receipt of stockholder approval of a new equity incentive plan.

Represents an award of restricted stock units vesting on the earlier of the (i) first anniversary of the Director's appointment to the Board of Directors of the Company and (ii) a change in control; provided that the award is expressly conditioned upon the receipt of stockholder approval of a new equity incentive plan.

Represents an award of restricted stock units vesting on the earlier of the (i) first anniversary of the Director's appointment to the Board of Directors of the Company and (ii) a change in control; provided that the award is expressly conditioned upon the receipt of stockholder approval of a new equity incentive plan.

Represents an award of restricted stock units vesting on the earlier of the (i) first anniversary of the Director's appointment to the Board of Directors of the Company and (ii) a change in control; provided that the award is expressly conditioned upon the receipt of stockholder approval of a new equity incentive plan.

Represents an award of restricted stock units vesting on the earlier of the (i) first anniversary of the Director's appointment to the Board of Directors of the Company and (ii) a change in control; provided that the award is expressly conditioned upon the receipt of stockholder approval of a new equity incentive plan.

Represents an award of restricted stock units vesting on the earlier of the (i) first anniversary of the Director's appointment to the Board of Directors of the Company and (ii) a change in control; provided that the award is expressly conditioned upon the receipt of stockholder approval of a new equity incentive plan.

Each share of Series E Preferred Stock is convertible into 2.4 shares of the Issuer's Common Stock.

The Series E Preferred Stock is perpetual and therefore has no expiration date.

Amended from "S" to "P"

Amended from "S" to "P"

On July 30, 2024, David E. Lazar (the "Reporting Person") entered into a securies purchase agreement with AEI Capital Group, a third party, pursuant to which the Reporting Person sold (i) 550,000 shares of Series E Convertible Preferred Stock (the "Series E Preferred Stock") of OpGen, Inc. (the "Company") and (ii) the rights to acquire an additional 2,450,000 shares of Series E Preferred Stock for $2,450,000 pursuant to an agreement between the Reporting Person and the Company.

The shares of Series E Preferred Stock are convertible at the option of the Reporting Person for no additional consideration.

The Series E Preferred Stock is perpetual and therefore has no expiration date.

On March 25, 2024, David E. Lazar (the "Reporting Person") and OpGen, Inc. (the "Company"), entered into a securies purchase agreement pursuant to which the Reporting Person will acquire an aggregate of 3,000,000 shares of the Company's Series E Convertible Preferred Stock (the "Series E Preferred Stock") at a price of $1.00 per share. Each share of Series E Preferred Stock is convertible into 24 shares of the Company's Common Stock at any time, subject to certain ownership limitations. The initial closing took place on March 25, 2024, whereby the Reporting Person acquired 200,000 shares of Series E Preferred Stock for a total purchase price of $200,000. On April 23, 2024, the Reporting Person acquired an additional 150,000 shares of Series E Preferred Stock for a total purchase price of $150,000. The Reporting Person will acquire additional shares of Series E Preferred Stock at subsequent closings, subject to certain conditions being satisfied.

The shares of Series E Preferred Stock are convertible at the option of the Reporting Person for no additional consideration.

This Form 4/A is being filed solely to change the transaction code previously provided to identify the transaction reported as exempt from Section 16(b) pursuant to Rule 16b-3

The Series E Preferred Stock is perpetual and therefore has no expiration date.

The reported number of shares of Common Stock underlying the shares of Series E Preferred Stock has been adjusted to reflect a reverse stock split of the Company's Common Stock effective as of May 20, 2024.

Shares of restricted stock issued pursuant to the 2015 Equity Incentive Plan of OpGen, Inc.

Shares of restricted stock issued pursuant to the 2015 Equity Incentive Plan of OpGen, Inc.

Shares of restricted stock issued pursuant to the 2015 Equity Incentive Plan of OpGen, Inc.

Shares of restricted stock issued pursuant to the 2015 Equity Incentive Plan of OpGen, Inc.

On March 25, 2024, David E. Lazar (the "Reporting Person") and OpGen, Inc. (the "Company"), entered into a securies purchase agreement pursuant to which the Reporting Person will acquire an aggregate of 3,000,000 shares of the Company's Series E Convertible Preferred Stock (the "Series E Preferred Stock") at a price of $1.00 per share. Each share of Series E Preferred Stock is convertible into 24 shares of the Company's Common Stock at any time, subject to certain ownership limitations. The initial closing took place on March 25, 2024, whereby the Reporting Person acquired 200,000 shares of Series E Preferred Stock for a total purchase price of $200,000. An additional closing occurred on April 5, 2024, whereby the Reporting Person acquired 200,000 shares of Series E Preferred Stock for a total purchase price of $200,000. The Reporting Person will acquire additional shares of Series E Preferred Stock at subsequent closings, subject to certain conditions being satisfied.

The shares of Series E Preferred Stock are convertible at the option of the Reporting Person for no additional consideration.

This Form 4/A is being filed solely to change the transaction code previously provided to identify the transaction reported as exempt from Section 16(b) pursuant to Rule 16b-3.

The Series E Preferred Stock is perpetual and therefore has no expiration date.

The reported number of shares of Common Stock underlying the shares of Series E Preferred Stock has been adjusted to reflect a reverse stock split of the Company's Common Stock effective as of May 20, 2024.

Represents an award of restricted stock units vesting on the first anniversary of the date of grant, or if earlier, the date of the 2024 annual meeting of stockholders, subject to acceleration and vesting if the director leaves the Board of Directors in connection with a change in control of OpGen, Inc. (the "Company").

The number of restricted stock units and shares reflects the application of the twenty-for-one reverse stock split effected by the Company on January 5, 2023.

Represents an award of restricted stock units vesting on the first anniversary of the date of grant, or if earlier, the date of the 2024 annual meeting of stockholders, subject to acceleration and vesting if the director leaves the Board of Directors in connection with a change in control of OpGen, Inc. (the "Company").

The number of restricted stock units and shares reflects the application of the twenty-for-one reverse stock split effected by the Company on January 5, 2023.

Represents an award of restricted stock units vesting on the first anniversary of the date of grant, or if earlier, the date of the 2024 annual meeting of stockholders, subject to acceleration and vesting if the director leaves the Board of Directors in connection with a change in control of OpGen, Inc. (the "Company").

The number of restricted stock units and shares reflects the application of the twenty-for-one reverse stock split effected by the Company on January 5, 2023.

Represents an award of restricted stock units vesting on the first anniversary of the date of grant, or if earlier, the date of the 2024 annual meeting of stockholders, subject to acceleration and vesting if the director leaves the Board of Directors in connection with a change in control of OpGen, Inc. (the "Company").

The number of restricted stock units and shares reflects the application of the twenty-for-one reverse stock split effected by the Company on January 5, 2023.

Represents an award of restricted stock units vesting on the first anniversary of the date of grant, or if earlier, the date of the 2024 annual meeting of stockholders, subject to acceleration and vesting if the director leaves the Board of Directors in connection with a change in control of OpGen, Inc. (the "Company").

The number of restricted stock units and shares reflects the application of the twenty-for-one reverse stock split effected by the Company on January 5, 2023.

Represents vesting of restricted stock units ("RSUs") granted to Reporting Person on March 31, 2022 that convert into common stock on a one-for-one basis as adjusted for a 1-for-20 reverse stock split.

On March 31, 2022, the Reporting Person was granted 12,469 RSUs (as adjusted for a 1-for-20 reverse stock split). The RSUs were granted subject to forfeiture, which forfeiture restrictions lapsed on the first anniversary of the date of grant.

Represents vesting of restricted stock units ("RSUs") granted to Reporting Person on March 31, 2022 that convert into common stock on a one-for-one basis as adjusted for a 1-for-20 reverse stock split.

On March 31, 2022, the Reporting Person was granted 6,434 RSUs (as adjusted for a 1-for-20 reverse stock split). The RSUs were granted subject to forfeiture, which forfeiture restrictions lapsed on the first anniversary of the date of grant.

Represents vesting of restricted stock units ("RSUs") granted in March 2021 that convert into common stock on a one-for-one basis as adjusted for a 1-for-20 reverse stock split.

On March 3, 2021, the Reporting Person was granted 2,125 RSUs (as adjusted for a 1-for-20 reverse stock split). The RSUs were granted subject to forfeiture, which forfeiture restrictions will lapse as to one half of the award on the first and second anniversaries of the date of grant, subject to acceleration as set forth in the Reporting Person's employment agreement with the Registrant.

Represents vesting of restricted stock units ("RSUs") granted in March 2021 that convert into common stock on a one-for-one basis as adjusted for a 1-for-20 reverse stock split.

On March 3, 2021, the Reporting Person was granted 3,875 RSUs (as adjusted for a 1-for-20 reverse stock split). The RSUs were granted subject to forfeiture, which forfeiture restrictions will lapse as to one half of the award on the first and second anniversaries of the date of grant, subject to acceleration as set forth in the Reporting Person's employment agreement with the Registrant.

Each RSU represents a contingent right to receive one share of OpGen common stock

RSUs granted on March 2, 2023 pursuant to the OpGen 2015 Equity Incentive Plan. The RSUs have a two year vesting schedule, vesting annually in equal installments on the anniversary of March 2, 2023.

Each RSU represents a contingent right to receive one share of OpGen common stock.

RSUs granted on March 2, 2023 pursuant to the OpGen 2015 Equity Incentive Plan. The RSUs have a two year vesting schedule, vesting annually in equal installments on the anniversary of March 2, 2023.

Represents vesting of restricted stock units ("RSUs") granted in March 2022 that convert into common stock on a one-for-one basis as adjusted for a 1-for-20 reverse stock split.

On March 2, 2022, the Reporting Person was granted 2,250 RSUs (as adjusted for a 1-for-20 reverse stock split). The RSUs were granted subject to forfeiture, which forfeiture restrictions will lapse as to one half of the award on the first and second anniversaries of the date of grant, subject to acceleration as set forth in the Reporting Person's employment agreement with the Registrant.

Each RSU represents a contingent right to receive one share of OpGen common stock.

RSUs granted on March 2, 2023 pursuant to the OpGen 2015 Equity Incentive Plan. The RSUs have a two year vesting schedule, vesting annually in equal installments on the anniversary of March 2, 2023.

Represents vesting of restricted stock units ("RSUs") granted in March 2022 that convert into common stock on a one-for-one basis as adjusted for a 1-for-20 reverse stock split.

On March 2, 2022, the Reporting Person was granted 3,750 RSUs (as adjusted for a 1-for-20 reverse stock split). The RSUs were granted subject to forfeiture, which forfeiture restrictions will lapse as to one half of the award on the first and second anniversaries of the date of grant, subject to acceleration as set forth in the Reporting Person's employment agreement with the Registrant.